www.santaanabio.com/Healthcare / BioTech & PharmaFounded: 2020Funding to Date: $168.34MM
Santa Ana Bio is a precision immunology company that strives to develop targeted therapies for autoimmune and inflammatory diseases. Santa Ana Bio was founded in 2022 and is headquartered in Alameda, CA. Through the use of its multi-omics platforms and antibody engineering, the company aims to deliver treatments that precisely target disease-causing cell types while avoiding healthy tissues.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
06/13/2024 | Series B-1 | $62.5MM | $xx.xx | $264.43MM | Access Biotechnology, Andreessen Horowitz, Gv, Rtw Investments, Tpg, Versant Ventures | |
Price per Share
$xx.xx
Shares Outstanding
52,083,329
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Participating
Participation Cap
3
Key Investors
Access Biotechnology, Andreessen Horowitz, Gv, Rtw Investments, Tpg, Versant Ventures
|
||||||
06/13/2024 | Series B-2 | $62.5MM | $xx.xx | $264.43MM | Access Biotechnology, Andreessen Horowitz, Gv, Rtw Investments, Tpg, Versant Ventures | |
Price per Share
$xx.xx
Shares Outstanding
41,666,664
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Participating
Participation Cap
3
Key Investors
Access Biotechnology, Andreessen Horowitz, Gv, Rtw Investments, Tpg, Versant Ventures
|
||||||
02/14/2023 | Series A | $35.31MM | $xx.xx | $78.8MM | Gv, Tpg, Versant Ventures | |
Price per Share
$xx.xx
Shares Outstanding
35,313,642
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Participating
Participation Cap
3
Key Investors
Gv, Tpg, Versant Ventures
|
||||||
05/17/2021 | Series Seed | $8.02MM | $xx.xx | $20.06MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
8,024,657
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Participating
Participation Cap
3
Key Investors
Undisclosed Investors
|